Kennedy Capital Management’s Avidity Biosciences RNAM Stock Holding History

Kennedy Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48,288	Closed	-$3.48M	–	572
2025 Q4	$3.48M	Buy	48,288 +695	+1%	+$44.9K	0.07%	355
2025 Q3	$2.07M	Buy	+47,593	New	+$1.92M	0.05%	444

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Kennedy Capital Management's RNAM Position: Q1 2026 in Review

Kennedy Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 48,288 shares — an estimated $3.48M sold.

Kennedy Capital Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $3.48M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Kennedy Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Kennedy Capital Management sold 48,288 Avidity Biosciences shares in Q1 2026, an estimated $3.48M.
Kennedy Capital Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Kennedy Capital Management's Avidity Biosciences position peaked at $3.48M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.